Where does SCPH stock trade?

scPharmaceuticals Inc. (SCPH) is listed on NASDAQ.

What sector and industry is SCPH in?

scPharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.

When did scPharmaceuticals Inc. go public?

scPharmaceuticals Inc. (SCPH) completed its IPO in 2017.

What are analysts saying about SCPH?

scPharmaceuticals Inc. has had 6 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $2000.00 price target on 2023-09-07. Recent price targets range from $600.00 to $2500.00.

What companies are similar to SCPH?

Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare SCPH side-by-side with any of them on Quantisnow.

How can I track SCPH on Quantisnow?

Quantisnow aggregates scPharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SCPH to receive live email and push alerts on every new disclosure.

SCPH

NASDAQ

scPharmaceuticals Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2017

$5.68+0.00 (+0.00%)

Follow Website

News25/Ratings6

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Price$5.68+1.70 (+42.89%)

2025-07-032025-10-06

Latest news

25 items

SCPH FAQ

7 questions

What does scPharmaceuticals Inc. do?
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by...
Where does SCPH stock trade?
scPharmaceuticals Inc. (SCPH) is listed on NASDAQ.
What sector and industry is SCPH in?
scPharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
When did scPharmaceuticals Inc. go public?
scPharmaceuticals Inc. (SCPH) completed its IPO in 2017.
What are analysts saying about SCPH?
scPharmaceuticals Inc. has had 6 recent analyst actions on file. The most recent action was from Craig Hallum: Buy with a $2000.00 price target on 2023-09-07. Recent price targets range from $600.00 to $2500.00.
What companies are similar to SCPH?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare SCPH side-by-side with any of them on Quantisnow.
How can I track SCPH on Quantisnow?
Quantisnow aggregates scPharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SCPH to receive live email and push alerts on every new disclosure.